by Histology is a branch of science that deals with the studies of structure and composition of animal and plant tissues through microscopic examination of their cells and tissues. It is closely associated with embryology and pathology. Histology techniques form the basis of microscopic diagnosis and comprehension of normal tissues and abnormal cell proliferations including tumors. Cytology deals with microscopic study of individual cells. Histology and cytology are important diagnostic tools in clinical pathology for detection of cancer and other diseases. The global histology and cytology market offers various consumables and instruments used in laboratories that conduct routine histopathology tests and cytology tests. The increasing prevalence of cancer is driving demand for histology and cytology procedures. It is estimated that over 1.8 million new cases of cancer were diagnosed and over 600,000 people died from cancer in 2022 in the United States alone.
The global Histology And Cytology Market is estimated to be valued at US$ 20,882.22 million in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Increasing Prevalence of Cancer – Cancer is one of the leading causes of death worldwide. According to WHO, cancer burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. The rising incidence of various types of cancer such as lung cancer, breast cancer, prostate cancer and colorectal cancer is a major factor boosting demand for accurate cancer diagnostics using histology and cytology techniques. This is expected to drive growth of the global histology and cytology market over the forecast period.
Higher Adoption of Personalized Medicine Approach – Personalized medicine tailors medical treatment to an individual’s characteristics, needs or predispositions. It involves using diagnostic tests to classify individuals into specific categories that determine whether they will likely respond to a particular drug or treatment. This increases reliance on tissue biopsy procedures for gene expression profiling, mutational analysis and evaluation of predictive biomarkers. It is driving demand for advanced histology and cytology solutions in clinical testing and research applications.
Segment Analysis
The global Histology and Cytology market is fragmented into five major segments based on products, applications, end-users, and geography. Based on products, the market is bifurcated into instruments, consumables, and services sub-segments. Among them, the consumables sub-segment is dominating the market, holding over 40% market share in 2023. This is attributed to the high demand and frequent need for consumables like reagents, chemicals, slides, and specimen processing kits during histopathological and cytological processes.
PEST Analysis
Political: Regulations regarding safety and handling of human biological samples are becoming stricter globally, favoring growth. However, varying reimbursement policies in different countries impact the market.
Economic: Rising healthcare spending, increasing incidence of chronic and infectious diseases, growing geriatric population undergoing diagnostics are driving market growth. High installation and maintenance costs of instruments initially pose challenges.
Social: Increasing awareness among patients regarding early disease diagnosis and preventive healthcare approaches boost demand. Stigma and cultural taboos around certain diseases in developing nations act as a restraint.
Technological: Adoption of advanced microscopy, molecular techniques, digital pathology, automated staining, and AI are enhancing productivity and clinical outcomes. Real-time remote diagnostics using telepathology gains traction.
Key Takeaways
The global Histology and Cytology Market Growth is expected to witness high growth at a CAGR of 10% during the forecast period of 2023 to 2030. The market size is projected to reach US$ 39,263.58 Mn by 2030 from US$ 20,882.22 Mn in 2023.
North America currently dominates with over 35% market share attributed to well-established healthcare infrastructure and rising cancer incidence. However, Asia Pacific is expected to witness the fastest growth rate owing to growing medical tourism industry, increasing healthcare investments, and expanding diagnostics sector in nations like China, India, and Japan.
Key players operating in the Histology and Cytology market are ABB, Xcel Energy Inc., EDF, National Grid Renewables, Acciona, Enel Spa, Innergex, The Tata Power Company Limited and General Electric. Among them, ABB is a frontrunner providing integrated diagnostic solutions and digital pathology systems. Xcel Energy Inc. leads the consumables segment with a wide product portfolio including reagents, chemicals, and stains. EDF is a major player focused on services like contract research and clinical trials.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
